Ensuring pharmaceutical safety and efficacy hinges on rigorous quality control (QC). By identifying potential microbial contaminants early in drug development and production, microbial QC tests ...
Recent studies in this field have indicated microbial cell-free DNA (mcfDNA) testing as a viable assay capable of identifying pathogens from the bloodstream. However, this technique has not been ...
In the ever-evolving landscape of pharmaceutical testing, ensuring the highest standards of microbial quality control (QC) is paramount. MicroQuant™, a cutting-edge solution from ATCC, is designed to ...
Using DNA sequencing for accurate identification of microbial infections in cystic fibrosis patients
Lung infections are a constant risk for people living with cystic fibrosis (CF), a life-threatening genetic disorder which ...
Researchers and therapeutic manufacturers have long relied on classical microbiological methods to check their samples and surfaces for microbial contamination, primarily using lengthy ...
Infectious diseases have been a major threat to human health throughout history, causing significant economic damage worldwide. In modern medicine, quickly and accurately identifying the germs causing ...
ASTM has worked diligently to develop a microbial barrier test for terminally sterilized packaging. In 1997, the European Committee for Standardization (CEN) and International Organization for ...
A rapid microbiological point-of-care test designed to help GPs identify whether a respiratory infection is caused by a virus did not lead to an expected overall reduction in same-day antibiotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results